Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent
An increasing number of broadly neutralizing antibodies (bnAbs) are considered leads for HIV-1 vaccine development and novel therapeutics. Here, we systematically explored the capacity of bnAbs to neutralize HIV-1 prior to and post-CD4 engagement and to block HIV-1 cell-cell transmission. Cell-cell...
Main Authors: | Reh, Lucia, Magnus, Carsten, Schanz, Merle, Weber, Jacqueline, Uhr, Therese, Rusert, Peter, Trkola, Alexandra |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497647/ |
Similar Items
-
Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?
by: Harini Subbaraman, et al.
Published: (2018-07-01) -
Cell-Cell Transmission Enables HIV-1 to Evade Inhibition by Potent CD4bs Directed Antibodies
by: Abela, Irene A., et al.
Published: (2012) -
Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain’s exceptional capacity for sequence variation
by: Brandenberg, Oliver F, et al.
Published: (2014) -
Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission
by: Malbec, Marine, et al.
Published: (2013) -
HIV-1 cell-to-cell transmission and broadly neutralizing antibodies
by: Jérémy Dufloo, et al.
Published: (2018-07-01)